KSM-66

KSM-66

Best for

Stay asleep through the night

Likely strong benefit · 120–600 mg/day for 10 weeks · 1 meta-analysis , n=339

36 papers · 14 claims · 137 outcomes scored · 13 positive

Outcomes

What ksm-66 actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Improve everyday quality of life Likely strong benefit
large
11 meta-analyses n=732 Meta-analyzed 1–600 mg 8–12 wk #1/61
Stay asleep through the night Likely strong benefit
large
2 meta-analyses n=339 Meta-analyzed 120–600 mg 10 wk #1/15
Fall asleep faster Likely strong benefit
large
2 meta-analyses n=339 Meta-analyzed 120–600 mg 10 wk #2/19
Lift and steady your mood Large effect, needs confirmation
large
2 RCTs n=90 125–600 mg 9–12 wk #2/20
Reduce daily stress Promising early signal
moderate
9 meta-analyses n=1.1k Meta-analyzed 0–6000 mg 4–12 wk #2/41
Build stronger muscles Promising early signal
moderate
4 meta-analyses n=153 Meta-analyzed 240–600 mg 4–8 wk #8/38
Improve overall sleep quality Likely modest benefit
small
7 meta-analyses n=596 Meta-analyzed 120–700 mg 4–12 wk #2/37
Lower day-to-day anxiety Likely modest benefit
small
7 meta-analyses n=500 Meta-analyzed 125–600 mg 8–12 wk #3/48
Ease anxiety in older adults Likely modest benefit
small
7 meta-analyses n=500 Meta-analyzed 125–600 mg 8–12 wk #3/45
Reduce pre-competition anxiety Likely modest benefit
small
7 meta-analyses n=500 Meta-analyzed 125–600 mg 8–12 wk #3/45
Ease your body's stress response Faint early signal
small
1 RCT n=90 125 mg 12 wk #1/2
Strengthen your memory Faint early signal
small
2 RCTs n=53 225–500 mg 4–8 wk #2/42
Strengthen planning and mental control Faint early signal
small
1 RCT n=53 250–500 mg 8 wk #7/28
Sharpen social processing Not enough research
1 RCT n=53 250–500 mg 8 wk

Risk profile

Adverse events and known drug interactions

Safety events

hepatotoxicity (drug-induced liver injury) severe
adrenal hypofunction (adrenal insufficiency) severe
adrenal_insufficiency / HPA axis suppression severe
thyrotoxicosis moderate
gastrointestinal discomfort (poor digestion / abdominal bloating) moderate
cough and cold moderate
acute dystonia (cervical dystonia and oculogyric crisis) moderate
Cushingoid features (facial puffiness) moderate

Sources

  1. 1. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. (2019)
  2. 2. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. (2021)
  3. 3. Efficacy and Tolerability of Ashwagandha Root Extract in the Elderly for Improvement of General Well-being and Sleep: A Prospective, Randomized, Double-blind, Placebo-controlled Study. (2020)
  4. 4. A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults. (2021)
  5. 5. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract for Improvement of Sexual Health in Healthy Women: A Prospective, Randomized, Placebo-Controlled Study. (2022)
  6. 6. A Study of Efficacy and Safety of Ashwagandha (Withania somnifera) Lotion on Facial Skin in Photoaged Healthy Adults. (2023)
  7. 7. Efficacy and safety of eight-week therapy with Ashwagandha root extract in improvement of sexual health in healthy men: Findings of a prospective, randomized, double-blind, placebo-controlled study. (2025)
  8. 8. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults. (2015)
  9. 9. Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: A randomized controlled trial. (2022)
  10. 10. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial. (2017)

Generated August 14, 2026

Want personalized recommendations?

Show me what works for me